Cancer
Researchers from the Materials Department have detailed new data in cancer gene therapy, showcasing the potential of surface-modified carbon dots (CDs) in targeted cancer therapies. According to the study, modified CDs have demonstrated remarkable potential in targeted drug delivery systems, enhancing solubility and specificity in tumor sites while minimizing systemic
Cancer
Researchers from Nankai University in Tianjin, People's Republic of China, have made a significant discovery in the field of cancer treatment. According to a new study published in Advanced Healthcare Materials, a new nanomedicine-based antitumor agent has been developed using traditional Chinese herbal medicine (TCHM). This innovative approach
Cancer
Research from Central South University, Hunan, People's Republic of China, has provided new insights into the role of the beta-2 adrenergic receptor (ADRB2) in regulating immune responses and its potential as a therapeutic target for cancer treatment. The study, published in the Journal for ImmunoTherapy of Cancer, found
Cancer
Cancer immunotherapy has revolutionized the treatment landscape of both hematological and solid cancers. However, despite initial success, T-cell-based adoptive cell transfer (ACT) therapies have been hindered by several obstacles, including a lack of antigen specificity, poor long-term survival of transplanted T cells, and a hostile tumor microenvironment. A team of
Cancer
A recent review of data on gastric cancer in Western populations has highlighted the limited cost-effectiveness of endoscopic screening and surveillance in detecting the disease. The study, conducted by researchers at Erasmus University Medical Center, found that while screening can reduce mortality rates, its cost-effectiveness in Western populations is unclear.
Cancer
Researchers at Saveetha Medical College and Hospital in Tamil Nadu, India, have made significant progress in the development of surfactant-based drug delivery systems for cancer gene therapy. These systems have the potential to revolutionize oncology treatments by improving drug efficacy, reducing systemic toxicity, and enabling precision medicine. Key Takeaways: * Surfactant-based
Cancer
Research conducted by scientists at the Fred Hutchinson Cancer Research Center has led to significant advancements in understanding the biology of gene regulation in eukaryotic genomes. According to the study, the biochemical principles of factor binding to DNA have been well-established through in vitro studies, and the structural interactions between
Cancer
Researchers from Wayne State University have made significant progress in developing cancer gene therapy, focusing on KRAS mutations that are common in various cancers and associated with aggressive disease and poor clinical outcomes. By understanding the binding process of KRAS to GDP/GTP, scientists have been able to design direct
Cancer
Research conducted at Islamic Azad University in Ardebil, Iran, has made significant strides in cancer gene therapy by successfully developing polyspermine-peg-glucose/DNA nanoparticles for targeted gene delivery to MCF-7 cells. This innovative approach utilizes cationic polymers to electrostatically interact with negatively charged DNA, enabling efficient and targeted delivery of genetic
Cancer
A recent study aimed to provide a comprehensive guideline for the evaluation of cardiovascular toxicity in pediatric cancer survivors using cardiac magnetic resonance imaging (MRI). The study, conducted by researchers at the University of Tennessee, aimed to standardize the approach to cardiac MRI assessment in this population, focusing on the
Cancer
New research from the School of Bio Sciences and Technology reveals the potential of artificial intelligence in cancer epigenomics to revolutionize early detection and precision medicine. The study highlights the importance of DNA methylation patterns in cancer diagnosis and prognosis, and how advanced analytical tools, such as AI and machine
Cancer
Scientists at Lomonosov Moscow State University have made significant advancements in the development of sorafenib delivery systems, a proven treatment for kidney cancer, to improve its bioavailability and expand its therapeutic potential to other oncological diseases. By leveraging biopolymers and supramolecular assemblies, researchers have created more sophisticated delivery systems with
